Skip to main content
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1998;7(3):153–155. doi: 10.1080/09629359891072

Smoking and nicotine in inflammatory bowel disease: good or bad for cytokines?

F J Zijlstra 1
PMCID: PMC1781849  PMID: 9705601

Abstract

Smoking has either a beneficial or harmful effect on the course and recurrence of ulcerative colitis and Crohn's disease respectively. Transdermal application of nicotine had similar effects in ulcerative colitis and therefore was considered to be an effective basic drug which could be further developed in the search for new compounds in the treatment of acute exacerbations of corticosteroid resistant ulcerative colitis. In this communication the short-term use of nicotine in ulcerative colitis is reviewed.

Full Text

The Full Text of this article is available as a PDF (116.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoshiba K., Nagai A., Yasui S., Konno K. Nicotine prolongs neutrophil survival by suppressing apoptosis. J Lab Clin Med. 1996 Feb;127(2):186–194. doi: 10.1016/s0022-2143(96)90077-3. [DOI] [PubMed] [Google Scholar]
  2. Benowitz N. L., Jacob P., 3rd Daily intake of nicotine during cigarette smoking. Clin Pharmacol Ther. 1984 Apr;35(4):499–504. doi: 10.1038/clpt.1984.67. [DOI] [PubMed] [Google Scholar]
  3. Calkins B. M. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci. 1989 Dec;34(12):1841–1854. doi: 10.1007/BF01536701. [DOI] [PubMed] [Google Scholar]
  4. Cottone M., Rosselli M., Orlando A., Oliva L., Puleo A., Cappello M., Traina M., Tonelli F., Pagliaro L. Smoking habits and recurrence in Crohn's disease. Gastroenterology. 1994 Mar;106(3):643–648. doi: 10.1016/0016-5085(94)90697-1. [DOI] [PubMed] [Google Scholar]
  5. Endoh K., Leung F. W. Effects of smoking and nicotine on the gastric mucosa: a review of clinical and experimental evidence. Gastroenterology. 1994 Sep;107(3):864–878. doi: 10.1016/0016-5085(94)90138-4. [DOI] [PubMed] [Google Scholar]
  6. Grabczewska E., Laskowska-Bozek H., Maśliński W., Ryzewski J. Cholinergic muscarinic and nicotinic binding by human lymphocytes: differences between peripheral blood cells and cultivated cell lines. Int J Tissue React. 1990;12(5):281–289. [PubMed] [Google Scholar]
  7. Hersey P., Prendergast D., Edwards A. Effects of cigarette smoking on the immune system. Follow-up studies in normal subjects after cessation of smoking. Med J Aust. 1983 Oct 29;2(9):425–429. [PubMed] [Google Scholar]
  8. Madretsma G. S., Donze G. J., van Dijk A. P., Tak C. J., Wilson J. H., Zijlstra F. J. Nicotine inhibits the in vitro production of interleukin 2 and tumour necrosis factor-alpha by human mononuclear cells. Immunopharmacology. 1996 Oct;35(1):47–51. doi: 10.1016/0162-3109(96)00122-1. [DOI] [PubMed] [Google Scholar]
  9. Madretsma S., Wolters L. M., van Dijk J. P., Tak C. J., Feyerabend C., Wilson J. H., Zijlstra F. J. In-vivo effect of nicotine on cytokine production by human non-adherent mononuclear cells. Eur J Gastroenterol Hepatol. 1996 Oct;8(10):1017–1020. doi: 10.1097/00042737-199610000-00016. [DOI] [PubMed] [Google Scholar]
  10. Morens D. M., Grandinetti A., Reed D., White L. R., Ross G. W. Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue? Neurology. 1995 Jun;45(6):1041–1051. doi: 10.1212/wnl.45.6.1041. [DOI] [PubMed] [Google Scholar]
  11. Pullan R. D., Rhodes J., Ganesh S., Mani V., Morris J. S., Williams G. T., Newcombe R. G., Russell M. A., Feyerabend C., Thomas G. A. Transdermal nicotine for active ulcerative colitis. N Engl J Med. 1994 Mar 24;330(12):811–815. doi: 10.1056/NEJM199403243301202. [DOI] [PubMed] [Google Scholar]
  12. Rhodes J., Thomas G. A. Smoking: good or bad for inflammatory bowel disease? Gastroenterology. 1994 Mar;106(3):807–810. doi: 10.1016/0016-5085(94)90719-6. [DOI] [PubMed] [Google Scholar]
  13. Saareks V., Riutta A., Mucha I., Alanko J., Vapaatalo H. Nicotine and cotinine modulate eicosanoid production in human leukocytes and platelet rich plasma. Eur J Pharmacol. 1993 Dec 1;248(4):345–349. doi: 10.1016/0926-6917(93)90012-f. [DOI] [PubMed] [Google Scholar]
  14. Srivastava E. D., Russell M. A., Feyerabend C., Rhodes J. Effect of ulcerative colitis and smoking on rectal blood flow. Gut. 1990 Sep;31(9):1021–1024. doi: 10.1136/gut.31.9.1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Söderholm J., Olaison G., Sjödahl R., Tagesson C. Smoking and intestinal absorption of oral polyethylene glycols in Crohn's disease. Scand J Gastroenterol. 1993 Feb;28(2):163–167. doi: 10.3109/00365529309096064. [DOI] [PubMed] [Google Scholar]
  16. Van Dijk J. P., Madretsma G. S., Keuskamp Z. J., Zijlstra F. J. Nicotine inhibits cytokine synthesis by mouse colonic mucosa. Eur J Pharmacol. 1995 May 4;278(1):R11–R12. doi: 10.1016/0014-2999(95)00211-3. [DOI] [PubMed] [Google Scholar]
  17. Zijlstra F. J., Srivastava E. D., Rhodes M., van Dijk A. P., Fogg F., Samson H. J., Copeman M., Russell M. A., Feyerabend C., Williams G. T. Effect of nicotine on rectal mucus and mucosal eicosanoids. Gut. 1994 Feb;35(2):247–251. doi: 10.1136/gut.35.2.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Zijlstra F. J., Vincent J. E., Mol W. M., Hoogsteden H. C., Van Hal P. T., Jongejan R. C. Eicosanoid levels in bronchoalveolar lavage fluid of young female smokers and non-smokers. Eur J Clin Invest. 1992 May;22(5):301–306. doi: 10.1111/j.1365-2362.1992.tb01466.x. [DOI] [PubMed] [Google Scholar]
  19. van Duijn C. M., Hofman A. Relation between nicotine intake and Alzheimer's disease. BMJ. 1991 Jun 22;302(6791):1491–1494. doi: 10.1136/bmj.302.6791.1491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. van Erpecum K. J., Smits S. J., van de Meeberg P. C., Linn F. H., Wolfhagen F. H., vanBerge-Henegouwen G. P., Algra A. Risk of primary sclerosing cholangitis is associated with nonsmoking behavior. Gastroenterology. 1996 May;110(5):1503–1506. doi: 10.1053/gast.1996.v110.pm8613056. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES